• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性肺炎球菌病与成人长期死亡率:加拿大艾伯塔省。

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada.

出版信息

Emerg Infect Dis. 2022 Aug;28(8):1615-1623. doi: 10.3201/eid2808.212469.

DOI:10.3201/eid2808.212469
PMID:35876489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9328901/
Abstract

The relationship between increased short-term mortality rates after invasive pneumococcal disease (IPD) has been frequently studied. However, the relationship between IPD and long-term mortality rates is unknown. IPD patients in Alberta, Canada, had clinical data collected that were linked to administrative databases. We used Cox proportional hazards modeling, and the primary outcome was time to all-cause deaths. First IPD events were identified in 4,522 patients, who had a median follow-up of 3.2 years (interquartile range 0.8‒9.1 years). Overall all-cause mortality rates were consistently higher among cases than controls at 30 days (adjusted hazard ratio [aHR] 3.75, 95% CI 3.29-4.28), 30‒90 days (aHR 1.56, 95% CI 1.27‒1.93), and >90 days (aHR 1.43, 95% CI 1.33-1.54). IPD increases risk for short, intermediate, and long-term mortality rates regardless of age, sex, or concurrent conditions. These findings can help clinicians focus on postdischarge patient plans to limit long-term effects after acute IPD infection.

摘要

侵袭性肺炎球菌病(IPD)后短期死亡率增加的关系已被频繁研究。然而,IPD 与长期死亡率之间的关系尚不清楚。加拿大艾伯塔省的 IPD 患者的临床数据被收集并与行政数据库相关联。我们使用 Cox 比例风险模型,主要结局是全因死亡的时间。在 4522 名患者中确定了首次 IPD 事件,中位随访时间为 3.2 年(四分位距 0.8-9.1 年)。在 30 天(调整后的危险比 [aHR] 3.75,95%置信区间 [CI] 3.29-4.28)、30-90 天(aHR 1.56,95% CI 1.27-1.93)和 >90 天(aHR 1.43,95% CI 1.33-1.54)时,病例的全因死亡率始终高于对照组。无论年龄、性别或并存疾病如何,IPD 都会增加短期、中期和长期死亡率的风险。这些发现可以帮助临床医生关注出院后患者的计划,以限制急性 IPD 感染后的长期影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/53ab9b703081/21-2469-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/a5e05d015011/21-2469-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/cc4209ab252d/21-2469-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/53ab9b703081/21-2469-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/a5e05d015011/21-2469-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/cc4209ab252d/21-2469-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa1/9328901/53ab9b703081/21-2469-F3.jpg

相似文献

1
Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada.侵袭性肺炎球菌病与成人长期死亡率:加拿大艾伯塔省。
Emerg Infect Dis. 2022 Aug;28(8):1615-1623. doi: 10.3201/eid2808.212469.
2
Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.艾伯塔省北部侵袭性肺炎球菌病:并非“红皇后”,而是一匹黑马。
Vaccine. 2018 May 17;36(21):2985-2990. doi: 10.1016/j.vaccine.2018.04.032.
3
Concurrent Infection with Hepatitis C Virus and Streptococcus pneumoniae.丙型肝炎病毒与肺炎链球菌的合并感染
Emerg Infect Dis. 2017 Jul;23(7):1118-1123. doi: 10.3201/eid2307.161858.
4
Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.加拿大卡尔加里七价和十三价肺炎球菌结合疫苗计划实施前后儿童侵袭性肺炎球菌疾病的性质和严重程度变化
Pediatr Infect Dis J. 2018 Jan;37(1):22-27. doi: 10.1097/INF.0000000000001709.
5
Invasive pneumococcal disease and long-term outcomes in children: A 20-year population cohort study.儿童侵袭性肺炎球菌疾病及其长期预后:一项为期20年的人群队列研究。
Lancet Reg Health Am. 2022 Aug 8;14:100341. doi: 10.1016/j.lana.2022.100341. eCollection 2022 Oct.
6
Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.1998 - 2007年加拿大侵袭性肺炎球菌疾病的流行病学变化:卡尔加里地区肺炎链球菌研究(CASPER)的最新情况
Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827.
7
Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.艾伯塔省卡尔加里市七种价肺炎球菌结合疫苗血清型所致侵袭性肺炎球菌病的消除。
Pediatr Infect Dis J. 2012 Sep;31(9):e169-75. doi: 10.1097/INF.0b013e3182624a40.
8
Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study.新加坡住院成人肺炎球菌病的流行病学、疫苗效力和死亡风险因素:一项病例对照研究。
BMC Infect Dis. 2020 Jun 17;20(1):423. doi: 10.1186/s12879-020-05140-1.
9
The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study.HIV 患者侵袭性肺炎球菌病的持续负担:一项观察性队列研究。
BMC Infect Dis. 2011 Nov 11;11:314. doi: 10.1186/1471-2334-11-314.
10
Factors predicting mortality in invasive pneumococcal disease in adults in Alberta.阿尔伯塔省成人侵袭性肺炎球菌疾病死亡率的预测因素。
Medicine (Baltimore). 2011 May;90(3):171-179. doi: 10.1097/MD.0b013e31821a5a76.

引用本文的文献

1
Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012-2022.侵袭性肺炎球菌疾病的血清型流行病学及病死率风险:一项2012 - 2022年瑞士全国性人群研究
Emerg Microbes Infect. 2025 Dec;14(1):2488189. doi: 10.1080/22221751.2025.2488189. Epub 2025 Apr 24.
2
Sex-based difference in immune responses and efficacy of the pneumococcal conjugate vaccine.肺炎球菌结合疫苗免疫反应和效力的性别差异。
J Leukoc Biol. 2024 Dec 31;117(1). doi: 10.1093/jleuko/qiae177.

本文引用的文献

1
Recent advances in the epidemiology and prevention of infections.感染病流行病学与预防的最新进展。
F1000Res. 2020 May 7;9. doi: 10.12688/f1000research.22341.1. eCollection 2020.
2
The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.2007-2017 年加拿大安大略省侵袭性肺炎球菌病的流行趋势和血清型分布变化。
PLoS One. 2019 Dec 13;14(12):e0226353. doi: 10.1371/journal.pone.0226353. eCollection 2019.
3
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
加拿大侵袭性感染中主要流行的肺炎链球菌血清型的分子特征:SAVE 研究,2011-2015 年。
J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii20-vii31. doi: 10.1093/jac/dky157.
4
Defining and measuring multimorbidity: a systematic review of systematic reviews.定义和测量多种疾病:系统综述的系统综述。
Eur J Public Health. 2019 Feb 1;29(1):182-189. doi: 10.1093/eurpub/cky098.
5
Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.艾伯塔省北部侵袭性肺炎球菌病:并非“红皇后”,而是一匹黑马。
Vaccine. 2018 May 17;36(21):2985-2990. doi: 10.1016/j.vaccine.2018.04.032.
6
Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments.侵袭性肺炎球菌疾病:仍有许多有待了解之处,且需要标准化的数据收集工具。
Can Respir J. 2017;2017:2397429. doi: 10.1155/2017/2397429. Epub 2017 Mar 23.
7
Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia.侵袭性肺炎球菌疾病(IPD)以及菌血症性与非菌血症性肺炎球菌肺炎后的长期死亡率。
Vaccine. 2017 Mar 27;35(14):1749-1757. doi: 10.1016/j.vaccine.2017.02.037. Epub 2017 Mar 3.
8
Increased long-term mortality after survival of invasive pneumococcal disease: a population-based study.生存的侵袭性肺炎球菌病后长期死亡率增加:一项基于人群的研究。
Infect Dis (Lond). 2017 May;49(5):365-372. doi: 10.1080/23744235.2016.1271997. Epub 2017 Jan 17.
9
The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study.2007年至2014年加拿大安大略省老年人侵袭性肺炎球菌疾病的流行病学:一项基于人群的研究。
CMAJ Open. 2016 Sep 29;4(3):E545-E550. doi: 10.9778/cmajo.20160035. eCollection 2016 Jul-Sep.
10
Serotype-specific differences in short- and longer-term mortality following invasive pneumococcal disease.侵袭性肺炎球菌病后短期和长期死亡率的血清型特异性差异。
Epidemiol Infect. 2016 Sep;144(12):2654-69. doi: 10.1017/S0950268816000856. Epub 2016 May 19.